Literature DB >> 12181047

Isolation of differentially expressed genes in NPM-ALK-positive anaplastic large cell lymphoma.

Claire Villalva1, Pascal Trempat, Catherine Greenland, Charles Thomas, Jean Philippe Girard, Fabian Moebius, Georges Delsol, Pierre Brousset.   

Abstract

In this study, we used subtractive suppression hybridization to compare gene expression between an ALK-positive anaplastic large cell lymphoma (ALCL)-derived cell line and a clinical case of ALK-negative ALCL. Construction and screening of a subtracted library resulted in the cloning of 29 cDNAs which were differentially expressed. Most of these clones corresponded to novel genes with unknown function (EST) or to genes implicated in the differentiation, activation or signalling of T cells such as Ran/TC4, interleukin 1-receptor, thymosin beta4, thymosin beta10, moesin and cytohesin-1. Other genes involved in the regulation of apoptosis, such as human inhibitor of apoptosis-1 (HIAP-1), Bax inhibitor-1 and MCL-1, or DNA repair, such as poly (ADP-ribose) polymerase 1 (PARP-1), X-associated protein-1 (XAP-1), SUMO-1 (sentrin-1) and RanGTPase-activating protein 1 (RanGAP-1), were isolated. Interestingly, we found that both RNA and protein levels of human sterol isomerase (hSI), also referred to as emopamil binding protein (EBP), were overexpressed in ALK+ tumours. This protein is involved in the biosynthesis of cholesterol and may be activated by NPM-ALK. Overall, our results suggest that all the genes described above are upregulated in the NPM-ALK-driven transformation process, and that moesin and cytohesin-1 may be more specifically implicated in a signalling pathway involving PLCgamma and PI3K.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12181047     DOI: 10.1046/j.1365-2141.2002.03671.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  15 in total

1.  Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes.

Authors:  Roberto Piva; Elisa Pellegrino; Michela Mattioli; Luca Agnelli; Luigia Lombardi; Francesco Boccalatte; Giulia Costa; Bruce A Ruggeri; Mangeng Cheng; Roberto Chiarle; Giorgio Palestro; Antonino Neri; Giorgio Inghirami
Journal:  J Clin Invest       Date:  2006-11-16       Impact factor: 14.808

2.  Mapping residues of SUMO precursors essential in differential maturation by SUMO-specific protease, SENP1.

Authors:  Zheng Xu; Shannon W N Au
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

3.  High expression of Mcl-1 in ALK positive and negative anaplastic large cell lymphoma.

Authors:  R Rust; G Harms; T Blokzijl; M Boot; A Diepstra; J Kluiver; L Visser; S-C Peh; M Lim; W A Kamps; S Poppema; A van den Berg
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

4.  The novel anticancer agent JNJ-26854165 induces cell death through inhibition of cholesterol transport and degradation of ABCA1.

Authors:  Richard J Jones; Dongmin Gu; Chad C Bjorklund; Isere Kuiatse; Alan T Remaley; Tarig Bashir; Veronique Vreys; Robert Z Orlowski
Journal:  J Pharmacol Exp Ther       Date:  2013-07-02       Impact factor: 4.030

5.  RanGTPase: A Key Regulator of Nucleocytoplasmic Trafficking.

Authors:  Ki Lui; Ying Huang
Journal:  Mol Cell Pharmacol       Date:  2009

6.  Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells.

Authors:  Michal Grzmil; Paul Thelen; Bernhard Hemmerlein; Stefan Schweyer; Silke Voigt; Dina Mury; Peter Burfeind
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

7.  Identification of novel cellular targets in biliary tract cancers using global gene expression technology.

Authors:  Donna E Hansel; Ayman Rahman; Manuel Hidalgo; Paul J Thuluvath; Keith D Lillemoe; Richard Schulick; Ja-Lok Ku; Jae-Gahb Park; Kohje Miyazaki; Raheela Ashfaq; Ignacio I Wistuba; Ram Varma; Lesleyann Hawthorne; Joseph Geradts; Pedram Argani; Anirban Maitra
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

8.  Identification and validation of genes involved in cervical tumourigenesis.

Authors:  Thangarajan Rajkumar; Kesavan Sabitha; Neelakantan Vijayalakshmi; Sundersingh Shirley; Mayil Vahanan Bose; Gopisetty Gopal; Ganesharaja Selvaluxmy
Journal:  BMC Cancer       Date:  2011-02-22       Impact factor: 4.430

9.  Yeast Bax inhibitor, Bxi1p, is an ER-localized protein that links the unfolded protein response and programmed cell death in Saccharomyces cerevisiae.

Authors:  James Cebulski; Joshua Malouin; Nathan Pinches; Vincent Cascio; Nicanor Austriaco
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

Review 10.  TMBIM protein family: ancestral regulators of cell death.

Authors:  D Rojas-Rivera; C Hetz
Journal:  Oncogene       Date:  2014-02-24       Impact factor: 8.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.